Author

Marco Gentilucci

Observed name: M Gentilucci

Observed institutions: Albert Einstein College of Medicine, University of Padua, University of Miami, Yeshiva University, Casa Sollievo della Sofferenza, University of California San Diego, Massachusetts General Hospital, Columbia University, University of Genoa

OpenAlex ID: A5000848680

REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial

2021 · Maurizio Fava, Stephen Stahl, et al. · American Journal of Psychiatry · 83

Nonselective β-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure

1997 · Laura Demopoulos, Michael Yeh, et al. · Circulation · 58

Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling

2022 · Stephen M. Stahl, Sara De Martin, et al. · International Journal of Molecular Sciences · 24

Modulation of vascular endothelial gene expression by physical training in patients with chronic heart failure.

2000 · M Testa, P V Ennezat, et al. · PubMed · 17

Clinical significance of fossa ovalis membrane aneurysm in adults with cardioembolic cerebral ischemia

1997 · Arzu Ilercil, Jay S. Meisner, et al. · The American Journal of Cardiology · 11

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms

2025 · Martina Colognesi, Daniela Gabbia, et al. · Pharmacological Research · 6

Calcium antagonists for the treatment of congestive heart failure

1994 · Andre J. Landau, Marco Gentilucci, et al. · Coronary Artery Disease · 4

Low level physical training improves peak oxygen consumption in patients with congestive heart failure despite long term beta adrenergic blockade by enhancing vascular conductance and growth

1996 · Laura Demopoulos, Marco Testa, et al. · Journal of the American College of Cardiology · 2

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

2026 · Anna Signor, Stefano Comai, et al. · British Journal of Clinical Pharmacology

788-4 Does Low Level Training Increase Peak Aerobic Capacity in Patients with Congestive Heart Failure?

1995 · Laura Demopoulos, Rachel Bijou, et al. · Journal of the American College of Cardiology

Works count: 10

Citation count: 205

H-index: 6

I10-index: 5